Today’s AI Top Pick: TMDX

7/6/2026 · Recently Alerted - Swing Setup screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Recently Alerted - Swing SetupTMDXBUY NOW8.6 / 107/6/2026

TransMedics (TMDX) is the cleanest swing setup in the pool right now: the fundamental screen thesis is intact (roe 45.22, profitMargin 27.04, salesYoY +30.24, epsNextY +72.22, analyst upside 70.4%, recom 1.64) and the price is deeply washed out — the weekly shows pos_in_21bar_range of just 7.31 with a drawdown of -52.36% from the 21-bar high, which is exactly the kind of location the brief asks for (not chasing, closer to lower end of range). This is not a name that has already run. The multi-timeframe forecast tape is convincingly bullish across all four horizons: 1h fc_mid +23.57 / fc_long +10.56, 4h fc_mid +78.46 / fc_long +103.21, 1d fc_short +66.44 / fc_mid +66.49 / fc_long +47.98, 1wk fc_mid +32.34 / fc_long +30.21. Every timeframe agrees on direction with kronos bullish_prob 1.0. The 1h/4h positions (69.26 and 25.38) are mid-range — the intraday tape isn't overextended, so entering today doesn't require chasing an outlier bar. Crucially, the news tape confirms rather than undercuts the thesis: 'TMDX Stock Rallies As Analyst Sees 77% Upside,' Motley Fool tagged it a 'Growth Stock to Buy on the Dip,' and the 10-year piece frames the long-duration story. Compare that to FUTU (score-tied at 15.5) which is buried under a fresh DOJ probe and US class actions dated 2026-07-03 — a clear landmine that disqualifies it as the #1 pick despite equally strong fundamentals. CALX also carries a class-action deadline overhang, and PFSI's forecast magnitudes are much smaller. Why today, not later: the 1h forecast is essentially flat (-0.46 short) meaning there's no near-term melt-up already priced in — you're getting in before the daily+ forecast (fc_short +66) plays out. Combined with a 52% weekly drawdown giving asymmetric R/R and a supportive analyst/news backdrop, this is the strongest confluence of screen-passing fundamentals + confirming tape + acceptable entry location in the pool.

Entry zone

$67.50-$70.00 (current $69.20, scale in on any intraday dip to the low $67s)

Stop loss

$61.50 (below the recent 4h/1d swing low; roughly -11% risk)

First target

$82-$85 (fills the daily gap area, ~20% move, aligns with 1d fc_short expectation)

Longer target

$105-$115 (retrace ~half the 52% weekly drawdown, aligns with 4h fc_long +103% zone)

Risks

Weekly drawdown of -52.36% signals a real trend break; if $61.50 support fails, next meaningful support is materially lower
shortFloat 23.02% — high short interest cuts both ways; if the tape rolls over, forced covering can vanish and downside accelerates
debtEq 1.75 is elevated for a med-tech; any capital raise would be dilutive at these prices
peg is null and fwdPe 20.3 is not cheap if EPS growth (+72.22% next Y) disappoints
1h/1d fc_short values are near flat/mildly positive — most of the upside is priced in mid/long horizons, so patience is required for the thesis to play out

Honorable mentions

PFSICleanest multi-timeframe alignment in the pool (1h/4h/1d/1wk all green, fc_mid 4h +21.88, 1d +19.61, 1wk +7.8) with fwdPe 5.97, peg 0.32, recom 1.62, and a fresh Piper Sandler Overweight reiteration; only knock is smaller analyst upside (25.8%) and debtEq 3.98.

CALXBest fundamental score (8) with strong daily forecast (fc_short +14.92, fc_mid +21.47), weekly pos_in_range only 14.57 (not extended), bullish_prob 1.0, and fwdPe 15.38/peg 0.41; downgraded from #1 because of the 'class action deadline' headline on 07-02 that creates event risk.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	TMDX	BUY NOW	8.6	Deep drawdown, all-timeframe bullish forecasts, positive dip-buying headlines, mid-range intraday entry.
2	PFSI	BUY NOW	8.1	Cleanest 4-TF green alignment, cheapest fwdPe (5.97), fresh analyst reiteration; smaller upside but low-risk entry.
3	CALX	BUY PULLBACK	7.5	Fund score 8, strong daily forecast, but at top of 1h/4h range and class-action headline creates event risk.
4	HSAI	BUY NOW	7.2	near_term_bullish 1.0, 1d fc_short +34.43, mid-range position, screen-clean fundamentals.
5	MNDY	BUY PULLBACK	6.9	Huge daily/weekly forecasts (+96-200%) post-earnings AI beat, but at top of intraday ranges and 1wk forecasts may be an outlier.
6	AVAV	BUY PULLBACK	6.7	Strong post-earnings momentum and positive UGV headlines, but 1h pos 97.27 = chasing; wait for pullback.
7	KRMN	BUY PULLBACK	6.5	4h fc_long +111%, defense backlog story with Citi Buy, but pe 249 and pos 91-100% on 1h/4h means don't chase.
8	BRZE	BUY PULLBACK	6.3	Goldman positive, AI acceleration, recom 1.09, but pos 96-99% across intraday TFs — wait for pullback.
9	FUTU	WAIT	6.0	Screen-perfect fundamentals but fresh DOJ probe + US class actions is a legitimate landmine — pass despite bullish forecasts.
10	BULL	WAIT	5.6	1h/4h forecasts negative near-term, valuation stretched, near_term_bullish only 0.4.
11	LEGN	BUY PULLBACK	5.5	near_term_bullish 1.0 and 1wk fc_mid +52.8, but 4h/1h fc_long negative and clinical binary risk.
12	CAI	WAIT	5.3	1d fc_long +76 is compelling but 1h fc_long -8.7 and no bullish_prob; mixed tape.
13	EQX	WAIT	5.0	Recom 1.0 and upside 103.7% look great but daily/weekly forecasts negative, bullish_prob 0.
14	VNET	WAIT	4.9	bullish_prob 1.0 and epsNextY 339% but debtEq 7.03, fund_score -0.25, governance headlines.
15	SRAD	BUY PULLBACK	4.8	1d fc_short +12.29 and near_term_bullish 1.0, but 1wk forecasts negative and no fresh catalyst.
16	FLY	WAIT	4.7	NASA $144M deal is positive but 4h fc_long -72.2 and profitMargin -193%; too speculative.
17	BKV	AVOID	4.4	1d/all forecasts negative and 'dilution fears' headline directly attacks the thesis.
18	TKC	WAIT	4.3	Cheap (peg 0.15) but modest forecasts and 1wk fc_short/mid/long all negative.
19	AG	AVOID	3.6	Daily/weekly forecasts deeply negative (-22 to -60%), bullish_prob 0, at top of intraday range.
20	TGB	AVOID	3.4	1d fc_short -26, 1wk fc_long -61.7, bullish_prob 0 — screen passes but tape is broken.
21	ARIS	AVOID	3.3	'New Strong Sell' headline plus 1wk fc_long -68 negates the fundamental case.
22	SVM	AVOID	3.2	Curtailing China operations headline plus 1d/1wk forecasts negative.
23	LC/HAPN	AVOID	3.1	All 4 timeframe forecasts negative (-7 to -37%) despite fund_score 8; broken setup.
24	HAPN	AVOID	3.0	Same underlying as LC, weekly forecasts -17 to -26%, no near-term bullishness.
25	SUPN	AVOID	3.0	'3 Reasons to Avoid' headline, 1wk fc_long -31, at top of range on 1h/4h/1d.
26	EXK	AVOID	2.9	1wk fc_short -37, fc_mid -50, near top of 1h/4h range.
27	TPC	AVOID	2.7	1wk fc_mid -74, 1d fc_long -25, at bottom of 1h/4h ranges — tape breaking down.
28	CECO	AVOID	2.5	1d fc_short -34, 1wk fc_mid -67; forecast tape says the 182% one-year run is unwinding.
29	BCRX	AVOID	2.4	Discontinuing internal discovery programs + closing facility is a strategic retreat despite analyst reiterations.
30	SEI	AVOID	2.2	Stock down 12.5% on guidance, 'above fair value' headline, shortFloat 29.19% — momentum broken.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord